DRTS vs. IRMD, AXGN, ZIMV, ZJYL, TMCI, NNOX, CLPT, BFLY, SGHT, and TCMD
Should you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include Iradimed (IRMD), AxoGen (AXGN), ZimVie (ZIMV), Jin Medical International (ZJYL), Treace Medical Concepts (TMCI), Nano-X Imaging (NNOX), ClearPoint Neuro (CLPT), Butterfly Network (BFLY), Sight Sciences (SGHT), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry.
Iradimed (NASDAQ:IRMD) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings, risk and community ranking.
92.3% of Iradimed shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 42.6% of Iradimed shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Iradimed and Iradimed both had 1 articles in the media. Alpha Tau Medical's average media sentiment score of 0.76 beat Iradimed's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.
Iradimed has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.
Iradimed has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.
Iradimed presently has a consensus target price of $60.00, suggesting a potential upside of 33.66%. Alpha Tau Medical has a consensus target price of $8.00, suggesting a potential upside of 251.65%. Given Alpha Tau Medical's higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than Iradimed.
Iradimed has a net margin of 26.83% compared to Alpha Tau Medical's net margin of 0.00%. Iradimed's return on equity of 24.71% beat Alpha Tau Medical's return on equity.
Iradimed received 236 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. However, 66.67% of users gave Alpha Tau Medical an outperform vote while only 64.78% of users gave Iradimed an outperform vote.
Summary
Iradimed beats Alpha Tau Medical on 11 of the 14 factors compared between the two stocks.
Get Alpha Tau Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alpha Tau Medical Competitors List
Related Companies and Tools
